Traditional Chinese medicine has unique advantages in preventing and treating COVID-19,and Fuzheng Jiedu decoction(FZJDD)was reported to be effective against COVID-19 in clinical trials.To investigate the potential me...Traditional Chinese medicine has unique advantages in preventing and treating COVID-19,and Fuzheng Jiedu decoction(FZJDD)was reported to be effective against COVID-19 in clinical trials.To investigate the potential mechanisms and material basis of FZJDD against SARS-CoV-2,we performed SARS-CoV-2 target protein inhibition analyses and a metabolite full spectrum analysis of FZJDD.Interestingly,FZJDD was found to block the binding of SARS-CoV-2 Spike protein with the receptor ACE2 and inhibit the activity of SARS-CoV-23CLpro.Moreover,FZJDD can regulate the TNF and the MAPK signaling pathway to inhibit the inflammatory response and alleviate the“cytokine storm”.A total of 298 compounds were identified in FZJDD,among them,caffeic acid and octyl gallate were found to be the potential therapeutic agents of FZJDD.Importantly,FZJDD can broadly inhibit coronavirus infection,including SADS-CoV and porcine epidemic diarrhea virus(PEDV)live viruses,SARS-CoV,MERS-CoV,and SARS-CoV-2 mutant pseudotyped viruses,which might be ascribed to the broad-spectrum anti-coronavirus activity of caffeic acid and octyl gallate.In conclusion,this study reveals the mechanisms and material basis of FZJDD against SARS-CoV-2 and identifies the broadspectrum anti-coronavirus activity of FZJDD for the first time.Our data provide empirical evidence for the development and application of FZJDD.展开更多
OBJECTIVE:To determine the effect of Traditional Chinese Medicine(TCM)Fuzheng Xuanfei Huashi prescription(扶正宣肺化湿方,FZXF)on lipopolysaccharide(LPS)-induced pneumonia in mice and identify the mechanism of FZXF in ...OBJECTIVE:To determine the effect of Traditional Chinese Medicine(TCM)Fuzheng Xuanfei Huashi prescription(扶正宣肺化湿方,FZXF)on lipopolysaccharide(LPS)-induced pneumonia in mice and identify the mechanism of FZXF in the treatment of LPS-induced lung inflammation.METHODS:The pneumonia model was established by intraperitoneal injection of 5 mg/kg LPS in mice.Cytokines were detected by enzyme-linked immuneosorbent assay(ELISA),macrophages in lung tissue were determined by immunofluorescence,and pathwayrelated data were determined by quantitative real-time polymerase chain reaction(qPCR)and Western blot.RESULTS:The liver,thymus,and spleen index values and the levels of aspartate aminotransferase(AST)and alanine aminotransferase(ALT)obviously increased in LPS-treated mice.FZXF decreased the white blood cell count and reduced the increase in the lung wet weight/dry weight ratio caused by LPS.The hematoxylin-eosin staining result showed that FZXF could maintain the integrity of lung tissue structure,alleviate interstitial oedema and alveolar wall thickening,and reduce inflammatory cell infiltration.Moreover,FZXF markedly reduced the expression of proinflammatory cytokines.FZXF also significantly reduced LPS-induced malondialdehyde production and increased superoxide dismutase level in the lung.By immunofluorescence,we found that FZXF could reduce macrophage infiltration.The mRNA expression levels of cyclooxygenase-2(COX-2),prostaglandin E2(PGE2),toll-like receptor 4(TLR4)and nuclear transcription factorκB(NF-κB)in the lung tissue of mice were decreased by treatment with FZXF.In addition,FZXF inhibited the protein expression of TLR4,p-p65 and COX-2.These results indicated that FZXF could inhibit the inflammatory response of LPS induced cytokine storm in mice through TLR4/NF-κB and COX-2/PGE2 signaling pathway.CONCLUSION:These findings were suggested that FZXF prescription suppresses inflammation in LPSinduced pneumonia in mice via TLR4/NF-κB and COX-2/PGE2 pathway.展开更多
Objective To elucidate the mechanism of Fuzheng Gankang Pill in treating combined allergic rhinitis and asthma syndrome(CARAS)with lung-spleen qi deficiency and wind-cold invading the lung syndrome using network pharm...Objective To elucidate the mechanism of Fuzheng Gankang Pill in treating combined allergic rhinitis and asthma syndrome(CARAS)with lung-spleen qi deficiency and wind-cold invading the lung syndrome using network pharmacology and molecular docking.MethodsThe active components and targets of the 13 herbs in Fuzheng Gankang Pill were retrieved from the TraditionalChinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP)and HERB.A“core herb-active component-target"network was constructed using Cytoscape to screen core components.CARAS disease targets were obtained from Genecards,NationalCenter for Biotechnology Information(NCBI),and Online Mendelian Inheritance in Man(OMIM).Targets related to the clinical phenotypes of CARAS with lung-spleen qi deficiency and wind-cold invading the lung syndrome were retrieved from the Traditional ChineseMedicineSyndrome Ontology and Multidimensional Quantitative Association Calculation Platform.The intersection of CARAS disease targets and syndromerelated targets yielded CARAS disease-syndrome targets.The intersection of Fuzheng Gankang Pill component-related targets and CARAS disease-syndrome targets provided“disease-syndrome-formula”intersection targets.These targets were uploaded to the STRING database for protein-protein interaction(PPI)network analysis,with topological analysis identifying key targets.Metascape was used for Gene Ontology(GO)enrichment analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway analysis.Molecular docking validation was performed using AutoDock Vina 1.1.2.Results The 13 core herbs of Fuzheng Gankang Pill contain a total of 200 active ingredients and 289 related targets.There are 2,412 disease targets for CARAS and 735 corresponding disease targets for the main and secondary symptoms of lung-spleen qi deficiency and wind-cold invading the lung.Through the Venn diagram,a total of 35 intersecting targets were obtained for Fuzheng Gankang Pill,CARAS,and the combination of lung-spleen qi deficiency and wind-cold invading the lung syndrome.Quercetin,Polygonatum sibiricum flavonoids,β-sitosterol,baicalein,kaempferol,etc.,are core components.PPI network analysis found that tumor necrosis factor(TNF),prostaglandin-endoperoxide synthase 2(PTGS2),interleukin(IL)-1β,IL-6,transforming growth factor beta 1(TGFβ1),BCL2,etc.,are the core targets for the compound to exert therapeutic effects.GO enrichment analysis showed that the 13 core drugs of Fuzheng Gankang Pill mainly participate in key biological processes such as positive regulation of protein modification,response to hormones,and negative regulation of cell population proliferation through protein kinases in areas such as membrane rafts,membrane microregions,plasma membrane protein complexes,and receptor com-plexes.KEGG enriched a total of 30 signaling pathways.Molecular docking shows that active ingredients such as quercetin and kaempferol bind stably toTNF(binding energy≤-9.0 kcal·mol^(-1))and PTGS2(≤-8.5kcal·mol^(-1)).Conclusion Fuzheng Gankang Pill may regulate biological processes such as cell apoptosis,tissue remodeling,inflammatory response,and immune response by acting on core targets such as TNF and PTGS2 through its core components quercetin,baicalein,β-sitosterol,baicalein,and kaempferol,thereby exerting therapeutic effects on CARAS with lung-spleen qi deficiency and wind-cold invading the lung syndrome.展开更多
Objective:To explore the clinical efficacy of traditional Chinese medicine Fuzheng Quxie tea drinking package in the treatment of Zhengxu Xielian type cancer.Methods:In this study,50 cases of Zhengxu Xielian type canc...Objective:To explore the clinical efficacy of traditional Chinese medicine Fuzheng Quxie tea drinking package in the treatment of Zhengxu Xielian type cancer.Methods:In this study,50 cases of Zhengxu Xielian type cancer admitted to our hospital from January 2020 to December 2021 were selected.They were divided into a control group(n=25)and a treatment group(n=25)according to the random number table method.The control group received conventional symptomatic treatment plus adjuvant therapy for cancer while the treatment group received traditional Chinese medicine Fuzheng Quxie tea drinking package plus conventional symptomatic treatment and adjuvant cancer therapy.Tumor marker indexes,quality of life scores,and fatigue scores before and after treatment were compared and analyzed between the two groups.Results:After treatment,the CEA,CA125,and NSE indexes in the treatment group were lower than those in the control group,and the differences were statistically significant(P<0.05).After treatment,the quality of life scores of the treatment group were better,and the data between the two groups were statistically significant(P<0.05).After treatment,the fatigue score of the observation group was significantly lower at 67.56±4.69 compared to 110.59±10.59 in the control group(t=18.576,P<0.05).Conclusion:The treatment of Zhengxu Xielian type cancer patients with traditional Chinese medicine Fuzheng Quxie tea drinking package can significantly reduce tumor marker indexes,improve patients’quality of life,and reduce fatigue,which has clinical significance.展开更多
[Objectives]This study aims to establish the quality standard of Fuzheng Wangan granules.[Methods]The qualitative identification of Radix Bupleuri and Radix Paeoniae Alba was carried out by the thin layer chromatograp...[Objectives]This study aims to establish the quality standard of Fuzheng Wangan granules.[Methods]The qualitative identification of Radix Bupleuri and Radix Paeoniae Alba was carried out by the thin layer chromatography(TLC).The content of ginsenosides Rg1,Re and Rb was determined by the high performance liquid chromatography(HPLC).[Results]The spots of Radix Bupleuri and Radix Paeoniae Alba were clear,and the negative control had no interference.The total content of ginsenoside Rg1,Re and Rb ranged from 0.0762 to 0.0739 mg/g.[Conclusions]The method for the quality control of Fuzheng Wangan granules established in this study is stable and feasible.展开更多
目的扶正化瘀方治疗子宫内膜异位症(EM)具有明确的临床疗效,在前期研究中证实,可能与抑制血管生成相关,本研究聚焦于这一研究热点,探索扶正化瘀方治疗EM的作用机制。方法本研究分为两个部分,第一部分进行生物信息学分析,获取扶正化瘀方...目的扶正化瘀方治疗子宫内膜异位症(EM)具有明确的临床疗效,在前期研究中证实,可能与抑制血管生成相关,本研究聚焦于这一研究热点,探索扶正化瘀方治疗EM的作用机制。方法本研究分为两个部分,第一部分进行生物信息学分析,获取扶正化瘀方的药物靶点,EM相关差异表达基因及血管生成的靶点,鉴定出前6位“EM核心靶点”,并在GSE58178芯片中获取“EM核心靶点”的正常组与模型组样本的表达矩阵信息,绘制差异分组比较图,构建TFmRNA-miRNA网络,筛选其作用的核心靶点;第二部分进行动物实验验证。通过同种异体子宫内膜移植法建立EM大鼠模型,将模型大鼠分为模型组、中药组及阳性对照组,每组6只,并设置假手术组6只作为对照,灌胃治疗14 d后取材,对血清及内膜组织进行检测,采用酶联免疫吸附测定检测血清糖类抗原125(CA125)、血管内皮生长因子(VEGF)等相关指标水平,采用逆转录实时定量聚合酶链式反应法检测正常/异位内膜组织miR-199a-5p、低氧诱导因子1α(HIF-1α)、VEGF等相关分子mRNA的表达情况。结果通过生物信息学分析得出,在血管生成这一关键环节,扶正化瘀方可能通过下调HIF-1α、VCAM1、STAT3、SERPINE1,上调MMP2、PDCFRB表达起到干预EM血管生成,延缓异位病灶生长的作用,并构建“TF-m RNA-mi RNA网络”,经过动物实验验证,相比于模型组,中药组血清CA125、VEGF水平显著降低,异位病灶体积显著缩小,且miR-199a-5p表达升高,HIF-1α、VEGF表达降低[(9.99±1.01)U/mL vs(14.60±0.65)U/mL,P<0.05;(170.04±29.40)pg/mL vs(245.42±36.10)pg/mL,P<0.05;(6.41±2.11)mm^(3) vs(23.92±4.63)mm^(3),P<0.05;0.80±0.08 vs 0.02±0.01,P<0.05;1.28±0.06 vs 2.21±0.32,P<0.05;1.29±0.23 vs 3.79±0.80,P<0.05]。结论扶正化瘀方可能通过下调HIF-1α、VEGF等因子表达,干预血管生成这一关键环节,缩小EM异位病灶,延缓EM进一步发展。展开更多
目的:探讨扶正口服汤联合奥沙利铂及卡培他滨(Oxaliplatin and Capecitabine,XELOX)化疗方案对结直肠癌患者卡氏功能状态评分(Karnofsky performance status score,KPS)及毒副反应发生率的影响。方法:前瞻性选取2020年5月至2024年5月我...目的:探讨扶正口服汤联合奥沙利铂及卡培他滨(Oxaliplatin and Capecitabine,XELOX)化疗方案对结直肠癌患者卡氏功能状态评分(Karnofsky performance status score,KPS)及毒副反应发生率的影响。方法:前瞻性选取2020年5月至2024年5月我院收治的122例结直肠癌患作为研究对象。根据随机信封法将所有患者分为研究组和对照组,各61例。对照组采用XELOX化疗方案治疗,研究组在对照组的基础上加用扶正口服汤治疗,两组均持续治疗8个疗程。比较两组临床疗效,并于治疗前后采用中医证候积分及KPS评分评估两组临床症状及生存质量;比较两组的免疫功能(CD3^(+)、CD4^(+)/CD8^(+)、NK细胞、CD8^(+)),以及两组治疗期间的毒副反应发生情况。结果:研究组疾病控制率明显高于对照组(P<0.05)。治疗后,研究组中医证候积分、CD8^(+)、Ⅰ-Ⅱ级的毒副反应发生率明显低于对照组;研究组KPS评分、CD3^(+)、CD4^(+)/CD8^(+)、NK明显高于对照组(P<0.05)。结论:扶正口服汤联合XELOX化疗方案可有效提高结直肠癌患者疗效,改善免疫功能及KPS评分,减轻化疗毒副作用。展开更多
基金supported by National Key Research and Development Program of China(grant No.2022YFC0867500,2020YFA0712102)National Natural Science Foundation of China(grant No.82151224,82202492)+3 种基金Fundamental Research Funds for Central Universities(grant No.QNTD 2023-01)Nutrition and Care of Maternal&Child Research Project of Biostime Institute of Nutrition&Care(grant No.2023BINCMCF28)State Key Laboratory of Pathogen and Biosecurity of China(grant No.SKLPBS2438)State Key Laboratory of Component-based Chinese Medicine(grant No.CBCM2024204).
文摘Traditional Chinese medicine has unique advantages in preventing and treating COVID-19,and Fuzheng Jiedu decoction(FZJDD)was reported to be effective against COVID-19 in clinical trials.To investigate the potential mechanisms and material basis of FZJDD against SARS-CoV-2,we performed SARS-CoV-2 target protein inhibition analyses and a metabolite full spectrum analysis of FZJDD.Interestingly,FZJDD was found to block the binding of SARS-CoV-2 Spike protein with the receptor ACE2 and inhibit the activity of SARS-CoV-23CLpro.Moreover,FZJDD can regulate the TNF and the MAPK signaling pathway to inhibit the inflammatory response and alleviate the“cytokine storm”.A total of 298 compounds were identified in FZJDD,among them,caffeic acid and octyl gallate were found to be the potential therapeutic agents of FZJDD.Importantly,FZJDD can broadly inhibit coronavirus infection,including SADS-CoV and porcine epidemic diarrhea virus(PEDV)live viruses,SARS-CoV,MERS-CoV,and SARS-CoV-2 mutant pseudotyped viruses,which might be ascribed to the broad-spectrum anti-coronavirus activity of caffeic acid and octyl gallate.In conclusion,this study reveals the mechanisms and material basis of FZJDD against SARS-CoV-2 and identifies the broadspectrum anti-coronavirus activity of FZJDD for the first time.Our data provide empirical evidence for the development and application of FZJDD.
基金Emergency Corona Virus Disease 2019(COVID-19)Response Project of Dongguan:Clinical Efficacy Observation and Mechanism Study of Fuzheng Xuanfei Huashi Formula in the Treatment of COVID-19 Based on the Lingnan Theory of Epidemic Diseases(No.202071715002124)National Natural Science Foundation of China:Study on the Mechanism of Lung Inflammatory Injury Induced by Gut-derived Lipopolysaccharide and Skatole in Spleen Deficiency Animals based on Pulmonary Alveolus Macrophage Heterogeneity(No.82274381)Guangdong Basic and Applied Basic Research Foundation:Development and Industrialization of Traditional Chinese Medicine Classic and Famous Prescription Compound Formulations(No.2021ZD006)。
文摘OBJECTIVE:To determine the effect of Traditional Chinese Medicine(TCM)Fuzheng Xuanfei Huashi prescription(扶正宣肺化湿方,FZXF)on lipopolysaccharide(LPS)-induced pneumonia in mice and identify the mechanism of FZXF in the treatment of LPS-induced lung inflammation.METHODS:The pneumonia model was established by intraperitoneal injection of 5 mg/kg LPS in mice.Cytokines were detected by enzyme-linked immuneosorbent assay(ELISA),macrophages in lung tissue were determined by immunofluorescence,and pathwayrelated data were determined by quantitative real-time polymerase chain reaction(qPCR)and Western blot.RESULTS:The liver,thymus,and spleen index values and the levels of aspartate aminotransferase(AST)and alanine aminotransferase(ALT)obviously increased in LPS-treated mice.FZXF decreased the white blood cell count and reduced the increase in the lung wet weight/dry weight ratio caused by LPS.The hematoxylin-eosin staining result showed that FZXF could maintain the integrity of lung tissue structure,alleviate interstitial oedema and alveolar wall thickening,and reduce inflammatory cell infiltration.Moreover,FZXF markedly reduced the expression of proinflammatory cytokines.FZXF also significantly reduced LPS-induced malondialdehyde production and increased superoxide dismutase level in the lung.By immunofluorescence,we found that FZXF could reduce macrophage infiltration.The mRNA expression levels of cyclooxygenase-2(COX-2),prostaglandin E2(PGE2),toll-like receptor 4(TLR4)and nuclear transcription factorκB(NF-κB)in the lung tissue of mice were decreased by treatment with FZXF.In addition,FZXF inhibited the protein expression of TLR4,p-p65 and COX-2.These results indicated that FZXF could inhibit the inflammatory response of LPS induced cytokine storm in mice through TLR4/NF-κB and COX-2/PGE2 signaling pathway.CONCLUSION:These findings were suggested that FZXF prescription suppresses inflammation in LPSinduced pneumonia in mice via TLR4/NF-κB and COX-2/PGE2 pathway.
基金supported by Special Project of Traditional Chinese Medicine Scientific Research in Henan Province(2023ZY1024,2022ZY1144)Special COVID-19 Research Project of Traditional Chinese Medicine in Henan Province(2022ZYFY08)+1 种基金Traditional Chinese Medicine Culture and Management Research Project in Henan Province(TCM2023005)Basic Scientific Research Business Fund Project of Henan Integrative Medicine Hospital(2304025,2304015)。
文摘Objective To elucidate the mechanism of Fuzheng Gankang Pill in treating combined allergic rhinitis and asthma syndrome(CARAS)with lung-spleen qi deficiency and wind-cold invading the lung syndrome using network pharmacology and molecular docking.MethodsThe active components and targets of the 13 herbs in Fuzheng Gankang Pill were retrieved from the TraditionalChinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP)and HERB.A“core herb-active component-target"network was constructed using Cytoscape to screen core components.CARAS disease targets were obtained from Genecards,NationalCenter for Biotechnology Information(NCBI),and Online Mendelian Inheritance in Man(OMIM).Targets related to the clinical phenotypes of CARAS with lung-spleen qi deficiency and wind-cold invading the lung syndrome were retrieved from the Traditional ChineseMedicineSyndrome Ontology and Multidimensional Quantitative Association Calculation Platform.The intersection of CARAS disease targets and syndromerelated targets yielded CARAS disease-syndrome targets.The intersection of Fuzheng Gankang Pill component-related targets and CARAS disease-syndrome targets provided“disease-syndrome-formula”intersection targets.These targets were uploaded to the STRING database for protein-protein interaction(PPI)network analysis,with topological analysis identifying key targets.Metascape was used for Gene Ontology(GO)enrichment analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway analysis.Molecular docking validation was performed using AutoDock Vina 1.1.2.Results The 13 core herbs of Fuzheng Gankang Pill contain a total of 200 active ingredients and 289 related targets.There are 2,412 disease targets for CARAS and 735 corresponding disease targets for the main and secondary symptoms of lung-spleen qi deficiency and wind-cold invading the lung.Through the Venn diagram,a total of 35 intersecting targets were obtained for Fuzheng Gankang Pill,CARAS,and the combination of lung-spleen qi deficiency and wind-cold invading the lung syndrome.Quercetin,Polygonatum sibiricum flavonoids,β-sitosterol,baicalein,kaempferol,etc.,are core components.PPI network analysis found that tumor necrosis factor(TNF),prostaglandin-endoperoxide synthase 2(PTGS2),interleukin(IL)-1β,IL-6,transforming growth factor beta 1(TGFβ1),BCL2,etc.,are the core targets for the compound to exert therapeutic effects.GO enrichment analysis showed that the 13 core drugs of Fuzheng Gankang Pill mainly participate in key biological processes such as positive regulation of protein modification,response to hormones,and negative regulation of cell population proliferation through protein kinases in areas such as membrane rafts,membrane microregions,plasma membrane protein complexes,and receptor com-plexes.KEGG enriched a total of 30 signaling pathways.Molecular docking shows that active ingredients such as quercetin and kaempferol bind stably toTNF(binding energy≤-9.0 kcal·mol^(-1))and PTGS2(≤-8.5kcal·mol^(-1)).Conclusion Fuzheng Gankang Pill may regulate biological processes such as cell apoptosis,tissue remodeling,inflammatory response,and immune response by acting on core targets such as TNF and PTGS2 through its core components quercetin,baicalein,β-sitosterol,baicalein,and kaempferol,thereby exerting therapeutic effects on CARAS with lung-spleen qi deficiency and wind-cold invading the lung syndrome.
基金Dai Yongfu’s Observation on the Clinical Effect of Traditional Chinese Medicine Fuzheng Quxie Tea Drinking Package in Treating Cancer of Zhengxu Xielian Type-A Key Scientific Research Project of the Ningxia Health and Family Planning Commission(Project No.:2019-NW-004).
文摘Objective:To explore the clinical efficacy of traditional Chinese medicine Fuzheng Quxie tea drinking package in the treatment of Zhengxu Xielian type cancer.Methods:In this study,50 cases of Zhengxu Xielian type cancer admitted to our hospital from January 2020 to December 2021 were selected.They were divided into a control group(n=25)and a treatment group(n=25)according to the random number table method.The control group received conventional symptomatic treatment plus adjuvant therapy for cancer while the treatment group received traditional Chinese medicine Fuzheng Quxie tea drinking package plus conventional symptomatic treatment and adjuvant cancer therapy.Tumor marker indexes,quality of life scores,and fatigue scores before and after treatment were compared and analyzed between the two groups.Results:After treatment,the CEA,CA125,and NSE indexes in the treatment group were lower than those in the control group,and the differences were statistically significant(P<0.05).After treatment,the quality of life scores of the treatment group were better,and the data between the two groups were statistically significant(P<0.05).After treatment,the fatigue score of the observation group was significantly lower at 67.56±4.69 compared to 110.59±10.59 in the control group(t=18.576,P<0.05).Conclusion:The treatment of Zhengxu Xielian type cancer patients with traditional Chinese medicine Fuzheng Quxie tea drinking package can significantly reduce tumor marker indexes,improve patients’quality of life,and reduce fatigue,which has clinical significance.
基金Supported by the Project for the Development and Promotion of Appropriate Technology of Traditional Chinese Medicine in Guangxi(GZSY2024017).
文摘[Objectives]This study aims to establish the quality standard of Fuzheng Wangan granules.[Methods]The qualitative identification of Radix Bupleuri and Radix Paeoniae Alba was carried out by the thin layer chromatography(TLC).The content of ginsenosides Rg1,Re and Rb was determined by the high performance liquid chromatography(HPLC).[Results]The spots of Radix Bupleuri and Radix Paeoniae Alba were clear,and the negative control had no interference.The total content of ginsenoside Rg1,Re and Rb ranged from 0.0762 to 0.0739 mg/g.[Conclusions]The method for the quality control of Fuzheng Wangan granules established in this study is stable and feasible.
文摘目的扶正化瘀方治疗子宫内膜异位症(EM)具有明确的临床疗效,在前期研究中证实,可能与抑制血管生成相关,本研究聚焦于这一研究热点,探索扶正化瘀方治疗EM的作用机制。方法本研究分为两个部分,第一部分进行生物信息学分析,获取扶正化瘀方的药物靶点,EM相关差异表达基因及血管生成的靶点,鉴定出前6位“EM核心靶点”,并在GSE58178芯片中获取“EM核心靶点”的正常组与模型组样本的表达矩阵信息,绘制差异分组比较图,构建TFmRNA-miRNA网络,筛选其作用的核心靶点;第二部分进行动物实验验证。通过同种异体子宫内膜移植法建立EM大鼠模型,将模型大鼠分为模型组、中药组及阳性对照组,每组6只,并设置假手术组6只作为对照,灌胃治疗14 d后取材,对血清及内膜组织进行检测,采用酶联免疫吸附测定检测血清糖类抗原125(CA125)、血管内皮生长因子(VEGF)等相关指标水平,采用逆转录实时定量聚合酶链式反应法检测正常/异位内膜组织miR-199a-5p、低氧诱导因子1α(HIF-1α)、VEGF等相关分子mRNA的表达情况。结果通过生物信息学分析得出,在血管生成这一关键环节,扶正化瘀方可能通过下调HIF-1α、VCAM1、STAT3、SERPINE1,上调MMP2、PDCFRB表达起到干预EM血管生成,延缓异位病灶生长的作用,并构建“TF-m RNA-mi RNA网络”,经过动物实验验证,相比于模型组,中药组血清CA125、VEGF水平显著降低,异位病灶体积显著缩小,且miR-199a-5p表达升高,HIF-1α、VEGF表达降低[(9.99±1.01)U/mL vs(14.60±0.65)U/mL,P<0.05;(170.04±29.40)pg/mL vs(245.42±36.10)pg/mL,P<0.05;(6.41±2.11)mm^(3) vs(23.92±4.63)mm^(3),P<0.05;0.80±0.08 vs 0.02±0.01,P<0.05;1.28±0.06 vs 2.21±0.32,P<0.05;1.29±0.23 vs 3.79±0.80,P<0.05]。结论扶正化瘀方可能通过下调HIF-1α、VEGF等因子表达,干预血管生成这一关键环节,缩小EM异位病灶,延缓EM进一步发展。
文摘目的:探讨扶正口服汤联合奥沙利铂及卡培他滨(Oxaliplatin and Capecitabine,XELOX)化疗方案对结直肠癌患者卡氏功能状态评分(Karnofsky performance status score,KPS)及毒副反应发生率的影响。方法:前瞻性选取2020年5月至2024年5月我院收治的122例结直肠癌患作为研究对象。根据随机信封法将所有患者分为研究组和对照组,各61例。对照组采用XELOX化疗方案治疗,研究组在对照组的基础上加用扶正口服汤治疗,两组均持续治疗8个疗程。比较两组临床疗效,并于治疗前后采用中医证候积分及KPS评分评估两组临床症状及生存质量;比较两组的免疫功能(CD3^(+)、CD4^(+)/CD8^(+)、NK细胞、CD8^(+)),以及两组治疗期间的毒副反应发生情况。结果:研究组疾病控制率明显高于对照组(P<0.05)。治疗后,研究组中医证候积分、CD8^(+)、Ⅰ-Ⅱ级的毒副反应发生率明显低于对照组;研究组KPS评分、CD3^(+)、CD4^(+)/CD8^(+)、NK明显高于对照组(P<0.05)。结论:扶正口服汤联合XELOX化疗方案可有效提高结直肠癌患者疗效,改善免疫功能及KPS评分,减轻化疗毒副作用。
